What Best Practices Should Laser Technicians Follow For Fractional Laser On Fitzpatrick Iv-V Skin? Safe Protocols For Darker Skin

For Fitzpatrick IV–V skin, fractional laser treatment should begin with conservative settings, controlled heat delivery, and a clear plan for preventing and managing pigmentary complications. Higher epidermal melanin increases absorption of laser energy, raising the risk of post-inflammatory hyperpigmentation (PIH), burns, blistering, prolonged hypopigmentation, and scarring. The safest approach is to reduce treatment density and fluence, cool the epidermis continuously, and pause between passes so heat can dissipate.

Darker skin is not an absolute contraindication to fractional laser treatment, but it requires a narrower safety margin. The objective is controlled fractional injury with adequate untreated skin between treatment zones, not maximum energy or coverage in a single session.

Why Fitzpatrick IV–V Skin Requires Modification

Epidermal Melanin Increases Heat Absorption

Fitzpatrick IV–V skin contains more epidermal melanin, which can absorb laser energy before it reaches the intended dermal target. This reduces the margin between a therapeutic thermal response and unintended epidermal injury.

The result can be immediate thermal damage or delayed pigmentary change, even when the treatment appears acceptable during the procedure.

PIH Can Follow a Mild Injury

PIH may develop after inflammation that is not visibly severe. Excessive density, overlapping pulses, aggressive passes, or inadequate cooling can stimulate melanocytes and create prolonged discoloration.

Patients should understand that fractional treatment can produce pigmentary complications even when there is no blistering or obvious burn.

Scarring Risk Must Be Considered

Darker phototypes may also have a greater tendency toward hypertrophic or keloid scarring. A history of abnormal scarring should therefore influence patient selection, treatment depth, and the threshold for proceeding.

Fractional delivery generally reduces thermal burden compared with fully ablative, non-fractionated resurfacing, but it does not eliminate scarring risk.

How to Plan the Treatment Safely

Perform a Precise Baseline Assessment

Document the patient’s Fitzpatrick type, current tan or recent sun exposure, baseline pigmentation, active inflammation, acne, dermatitis, infection, and history of PIH or abnormal scarring.

Recently tanned skin should generally not be treated until the tan has subsided and the skin barrier is stable. Review medications, previous procedures, and any condition that may impair healing or increase photosensitivity.

Set Realistic Treatment Goals

Determine whether the indication is acne scarring, textural irregularity, dyschromia, wrinkles, or another condition. The appropriate device, wavelength, depth, and treatment intensity depend on the target.

A conservative series of treatments is usually preferable to one highly aggressive session. Patients should be told that improvement may require more sessions and may occur more gradually.

Use a Test Area

Perform a test treatment in an inconspicuous area when the device, indication, or parameter combination is new to the patient. Observe both the immediate response and delayed healing or pigmentary response before treating a larger area.

A test spot does not guarantee safety, but it can reveal an excessive inflammatory or pigmentary response before full treatment.

Confirm Device-Specific Parameters

Fractional CO2, Er:YAG, and nonablative fractional systems differ substantially in wavelength, pulse structure, depth, density, and endpoint. Settings cannot be transferred reliably from one platform to another.

Use the manufacturer’s instructions, validated clinical protocols, applicable regulations, and the supervising clinician’s judgment. Technicians should operate only within their training and legal scope.

How to Adjust Fractional Laser Delivery

Reduce Fluence and Treatment Density

Begin with lower fluence and conservative coverage, particularly for a first treatment or when the patient has a history of PIH. Lower density leaves a larger reservoir of untreated skin to support re-epithelialization and heat dissipation.

For nonablative fractional treatments, coverage commonly needs to be substantially lower for darker phototypes than for lighter skin. The exact percentage must be determined by the device, indication, treatment level, and clinical protocol rather than applied as a universal rule.

Minimize Pulse Overlap

Avoid stacking pulses or repeatedly treating the same area unless the protocol specifically requires it. Minimal overlap reduces cumulative thermal injury and prevents localized hotspots.

Maintain a consistent handpiece speed and pattern. The handpiece should remain perpendicular to the skin when required by the device design, because angulation can alter energy distribution and treatment geometry.

Pause Between Passes

Intentional pauses allow heat to dissipate before additional energy is delivered. This is especially important when treating larger areas or when tissue temperature is rising across successive passes.

Do not interpret a longer treatment time as a failure of efficiency. In darker skin, controlled pacing is part of the safety protocol.

Maintain Continuous Epidermal Cooling

Use the platform’s active cooling system correctly and continuously where indicated. Cooling may include integrated contact cooling, air cooling, cryogen, or another validated method compatible with the device.

Cooling should protect the epidermis without obscuring the treatment endpoint or causing cold injury. Check that the cooling system is functioning before treatment and monitor the skin throughout the procedure.

Choose Fractional Rather Than Fully Ablative Delivery When Appropriate

Fractional treatment creates microscopic treatment zones separated by viable tissue. This generally limits the total area of thermal injury and supports faster healing than fully ablative resurfacing.

A fractional mode still requires careful control of depth, density, fluence, pulse duration, and overlap. The word “fractional” should not be treated as a guarantee against burns or PIH.

Consider Wavelength and Pulse Characteristics

When the clinical target permits, longer wavelengths may reduce superficial melanin absorption and reach deeper targets more selectively. This principle is particularly relevant to pigment or vascular treatments, where a 1064 nm Nd:YAG platform may be preferable to shorter, more melanin-absorbed wavelengths.

For fractional CO2 or Er:YAG treatment, the device’s wavelength is fixed, so safety depends heavily on conservative energy settings, pulse control, density, cooling, and spacing between passes. Longer pulse durations may reduce peak power in some systems, but this must follow the platform’s validated protocol.

Monitor the Patient During Treatment

Establish a Conservative Endpoint

Use the device-specific clinical endpoint rather than relying on a generic visual sign. Depending on the platform, expected findings may include uniform erythema, edema, pinpoint coagulation, or controlled microthermal change.

Whitening, epidermal rupture, bleeding, blistering, gray or charred tissue, or sharply demarcated excessive erythema should prompt immediate reassessment. A visual endpoint is not interchangeable across ablative and nonablative devices.

Watch for Heat Accumulation

Ask about escalating heat or pain and inspect the skin after each pass. Increasing discomfort, patchy intense erythema, unusual whitening, blistering, or a hot, sharply localized area indicates that treatment should be paused.

Do not continue simply because the programmed pass is incomplete. The patient’s tissue response takes priority over the planned number of passes.

Use Appropriate Marking Materials

Use white markers or another material specifically approved for the device and procedure. Dark markers can absorb laser radiation and create localized thermal injury.

Remove unapproved makeup, creams, or pigments that could alter energy absorption. Follow the equipment manufacturer’s instructions for marking and skin preparation.

Protect the Eyes and Adjacent Structures

Use wavelength-appropriate ocular protection for everyone in the treatment area. Treat carefully around thin skin, the eyelids, mucosal surfaces, and other anatomically sensitive sites.

Eye protection must be compatible with the specific wavelength and device. Ordinary eyewear or generic shields are not sufficient.

Prepare the Patient Before Treatment

Control Inflammation and Barrier Disruption

Do not treat over active infection, uncontrolled dermatitis, open wounds, or significant inflammation. A compromised barrier can increase pain, healing time, infection risk, and pigmentary complications.

Address active acne or other inflammatory conditions when appropriate before resurfacing. The skin should be clinically stable at the time of treatment.

Emphasize Photoprotection

Strict broad-spectrum photoprotection is essential before and after treatment. Avoiding tanning and minimizing ultraviolet exposure reduces the stimulus for PIH and protects healing skin.

Document compliance expectations clearly. Post-treatment sun exposure can undermine an otherwise appropriate laser protocol.

Discuss Pigment Risk Explicitly

Explain that darker skin types have a higher risk of PIH and that pigment changes may be delayed and prolonged. Also discuss less common but serious outcomes, including hypopigmentation, blistering, infection, and scarring.

Informed consent should address the possibility that the final result may be uneven or may require additional treatment.

Understanding the Trade-offs

Lower Settings May Require More Sessions

Conservative fluence and density reduce thermal risk but may produce less change per session. The practical trade-off is often a longer treatment course in exchange for a wider safety margin.

A series of controlled treatments is generally easier to manage than attempting to obtain the entire result through one aggressive session.

Cooling Does Not Correct Excessive Energy

Cooling protects the epidermis but cannot make an unsafe fluence or excessive overlap safe. It should be used as one part of parameter control, not as permission to increase energy.

Similarly, fractional delivery reduces the treated area but does not prevent injury when individual microthermal zones are too deep or too densely placed.

“More Aggressive” Is Not Always More Effective

Greater intensity can increase inflammation without producing proportionally better remodeling. In darker skin, excessive inflammation may create the very PIH or scarring that the treatment was intended to improve.

The most useful endpoint is a controlled therapeutic response followed by predictable healing, not the most dramatic immediate appearance.

Pigment-Specific Devices Need Extra Caution

IPL and pigment-targeting lasers can be particularly challenging in skin with high epidermal melanin because the epidermis may compete with the intended pigment target for absorbed energy. Parameters, filters, cooling, and test spots must be selected for the specific device and indication.

Do not extrapolate fractional resurfacing settings to IPL, Alexandrite, or other pigment-selective systems. These platforms have different chromophore interactions and risk profiles.

How to Apply This to Your Practice

Treatment should be individualized, documented, and performed under an established medical laser protocol.

If your primary focus is preventing PIH: Use conservative fluence and density, avoid recently tanned skin, minimize overlap, provide strict photoprotection, and use active cooling throughout treatment.
If your primary focus is resurfacing texture or acne scars: Prefer a fractional approach with controlled depth and a staged series of sessions instead of a single aggressive treatment.
If your primary focus is procedural safety: Perform a baseline assessment and test area, monitor tissue response after every pass, pause for heat dissipation, and stop when the endpoint becomes excessive.
If your primary focus is pigment or vascular treatment: Select the wavelength, filter, pulse duration, fluence, and cooling method specifically for darker phototypes, and do not reuse settings from lighter skin.
If your primary focus is technician consistency: Use device-specific checklists, approved marking materials, calibrated equipment, documented parameters, and clear escalation rules for unexpected endpoints.

For Fitzpatrick IV–V patients, the safest fractional laser treatment is controlled, cooled, deliberately paced, and conservative enough to preserve the epidermis while achieving the intended clinical response.

Summary Table:

Best Practice	Key Actions
Baseline Assessment	Document Fitzpatrick type, tan, history of PIH/scarring; avoid treating tanned skin.
Test Area	Perform a test spot before full treatment to observe pigmentary response.
Parameter Adjustment	Use lower fluence and density; minimize pulse overlap.
Cooling & Pacing	Maintain continuous epidermal cooling; pause between passes to dissipate heat.
Endpoint Monitoring	Watch for excessive erythema, whitening, or blistering; stop if these occur.
Post-Treatment Care	Strict photoprotection and explicit pigment risk discussion with the patient.

At BELIS, we specialize in professional-grade aesthetic devices designed for optimal safety and efficacy, even on darker skin types. Our advanced fractional lasers, such as CO2 and Erbium systems, feature precise settings and integrated cooling to help you deliver controlled treatments with confidence. Whether you're treating acne scars, texture, or pigmentation, our technology supports conservative, effective protocols. Protect your patients and enhance your practice—contact our experts today to learn how our solutions can elevate your results. Get in touch now!